Day

januar 7, 2019
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections, and Everest Medicines announced today that they have entered into a collaboration to develop, manufacture and commercialize SPR206 in Greater China, South Korea and certain...

Nyheder

Professor førte fransk forskerkvartet på sporet af sjælden hjernesygdom
19. marts 2019
Lundbeckfonden bag største serie A-investering i dansk biotek nogensinde
11. marts 2019
Lundbeckfonden belønner pioner-udredning af blodpropper i de små blodkar i hjernen
5. marts 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge